Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNA-051 influenza challenge study
NCT05255822Phase 2Completed
- Sponsor
- ENA Respiratory
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of INNA-051 in influenza, sponsored by ENA Respiratory. Started Feb 2022; status: completed.
02
Drugs
INNA-051
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05255822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05255822.